ES2572260T3 - Péptidos útiles en el tratamiento y/o cuidado de la piel y/o membranas mucosas y su uso en composiciones cosméticas o farmacéuticas - Google Patents

Péptidos útiles en el tratamiento y/o cuidado de la piel y/o membranas mucosas y su uso en composiciones cosméticas o farmacéuticas

Info

Publication number
ES2572260T3
ES2572260T3 ES12711623T ES12711623T ES2572260T3 ES 2572260 T3 ES2572260 T3 ES 2572260T3 ES 12711623 T ES12711623 T ES 12711623T ES 12711623 T ES12711623 T ES 12711623T ES 2572260 T3 ES2572260 T3 ES 2572260T3
Authority
ES
Spain
Prior art keywords
substituted
unsubstituted
group
cosmetic
care
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES12711623T
Other languages
English (en)
Inventor
Anton José María Garcia
Domenech Nuria Alminana
Montiel Antonio Vicente Ferrer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lipotec SA
Original Assignee
Lipotec SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipotec SA filed Critical Lipotec SA
Application granted granted Critical
Publication of ES2572260T3 publication Critical patent/ES2572260T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A61K8/068—Microemulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Birds (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Un péptido de fórmula general (I) R1-Wn-Xm-AA1-AA2-AA3-AA4-AA5-AA6-Yp-Zq-R2 (I) sus estereoisómeros, mezclas de los mismos y/o sus sales cosmética o farmacéuticamente aceptables, caracterizado porque: AA1 se selecciona del grupo formado por -Ser-, -Thr- y -Tyr-; AA2 se selecciona del grupo formado por -Pro- y -Val-; AA3 se selecciona del grupo formado por -Ala-; AA4 se selecciona del grupo formado por -Glu-, -Gly- y -Val-; AA5 se selecciona del grupo formado por -Gly-; AA6 se selecciona del grupo formado por -Gln-, -Gly-, -His- y -Pro-; W, X, Y, Z son aminoácidos y se seleccionan independientemente entre sí; n, m, p y q se seleccionan independientemente entre sí y tienen un valor de 0 o 1; n+m+p+q es menor o igual a 2; R1 se selecciona del grupo formado por H, grupo alifático no cíclico sustituido o no sustituido, aliciclilo sustituido o no sustituido, heterociclilo sustituido o no sustituido, heteroarilalquilo sustituido o no sustituido, arilo sustituido o no sustituido, aralquilo sustituido o no sustituido y R5-CO-, en el que R5 se selecciona del grupo formado por H, grupo alifático no cíclico sustituido o no sustituido, aliciclilo sustituido o no sustituido, arilo sustituido o no sustituido, aralquilo sustituido o no sustituido, heterociclilo sustituido o no sustituido y heteroarilalquilo sustituido o no sustituido; R2 se selecciona del grupo formado por -NR3R4, -OR3 y -SR3, en los que R3 y R4 se seleccionan independientemente del grupo formado por H, grupo alifático no cíclico sustituido o no sustituido, aliciclilo sustituido o no sustituido, heterociclilo sustituido o no sustituido, heteroarilalquilo sustituido o no sustituido, arilo sustituido o no sustituido, y aralquilo sustituido o no sustituido; y con la condición de que R1 y R2 no sean α-aminoácidos.
ES12711623T 2011-03-25 2012-03-23 Péptidos útiles en el tratamiento y/o cuidado de la piel y/o membranas mucosas y su uso en composiciones cosméticas o farmacéuticas Active ES2572260T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161467643P 2011-03-25 2011-03-25
ES201130441A ES2397890B1 (es) 2011-03-25 2011-03-25 Péptidos útiles en el tratamiento y/o cuidado de la piel y/o mucosas y su uso en composiciones cosméticas o farmacéuticas.
PCT/EP2012/055250 WO2012130771A1 (en) 2011-03-25 2012-03-23 Peptides useful in the treatment and/or care of the skin and/or mucous membranes and their use in cosmetic or pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ES2572260T3 true ES2572260T3 (es) 2016-05-31

Family

ID=46929507

Family Applications (2)

Application Number Title Priority Date Filing Date
ES201130441A Active ES2397890B1 (es) 2011-03-25 2011-03-25 Péptidos útiles en el tratamiento y/o cuidado de la piel y/o mucosas y su uso en composiciones cosméticas o farmacéuticas.
ES12711623T Active ES2572260T3 (es) 2011-03-25 2012-03-23 Péptidos útiles en el tratamiento y/o cuidado de la piel y/o membranas mucosas y su uso en composiciones cosméticas o farmacéuticas

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES201130441A Active ES2397890B1 (es) 2011-03-25 2011-03-25 Péptidos útiles en el tratamiento y/o cuidado de la piel y/o mucosas y su uso en composiciones cosméticas o farmacéuticas.

Country Status (9)

Country Link
US (1) US9067967B2 (es)
EP (1) EP2651963B1 (es)
JP (1) JP6075650B2 (es)
KR (1) KR101988675B1 (es)
CN (1) CN103314005B (es)
AU (1) AU2012234366B2 (es)
BR (1) BR112013020005A8 (es)
ES (2) ES2397890B1 (es)
WO (1) WO2012130771A1 (es)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11389663B2 (en) 2011-04-01 2022-07-19 Bioregentech, Inc. Laser assisted wound healing protocol and system
US11730760B2 (en) 2011-04-01 2023-08-22 The Bioregentech Institute, Inc. Laser assisted wound healing protocol and system
KR20160013020A (ko) * 2013-04-16 2016-02-03 몰레큘러 시스템즈, 리미티드 레이저 보조 치주 조직 및 뼈 재생 프로토콜
US20160000858A1 (en) 2014-07-07 2016-01-07 Gojo Industries, Inc. Compositions and methods for mitigating skin irritation and enhancing skin barrier function
WO2016063805A1 (ja) * 2014-10-21 2016-04-28 日産化学工業株式会社 レジスト下層膜形成組成物
EP3212688B1 (en) 2014-10-31 2022-04-13 Lubrizol Advanced Materials, Inc. Thermoplastic polyurethane film for delivery of active agents to skin surfaces
CN104523449A (zh) * 2015-01-08 2015-04-22 上海圣婕化妆品有限公司 一种抗衰老多胜肽复合物及其应用
CN104622779A (zh) * 2015-01-08 2015-05-20 上海圣婕化妆品有限公司 一种多胜肽抗衰老修复面膜精华液及其制备方法
US20170020798A1 (en) * 2015-02-25 2017-01-26 The Regents Of The University Of California Hesperidin-containing compositions and methods for treatment of skin disorders
EP3277255A1 (en) 2015-03-31 2018-02-07 GOJO Industries, Inc. Synergistic compositions and methods for mitigating skin irritation and enhancing skin barrier function
EP3118216A1 (en) 2015-07-16 2017-01-18 Nuritas Limited Cellular growth and proliferation promoting peptides, and uses thereof
EP3117830A1 (en) 2015-07-16 2017-01-18 Nuritas Limited Antibacterial peptides, and uses thereof
MX377692B (es) 2015-07-16 2025-03-10 Nuritas Ltd Peptidos anti-inflamatorios y usos de los mismos.
EP3118215A1 (en) 2015-07-16 2017-01-18 Nuritas Limited Anti-inflammatory peptides, and uses thereof
EP3117831A1 (en) 2015-07-16 2017-01-18 Nuritas Limited Peptides for use in promoting transport of glucose into skeletal muscle
CN104997693A (zh) * 2015-07-31 2015-10-28 魏善众 植物甾醇酯化妆品
CN105039030A (zh) * 2015-08-06 2015-11-11 吴敏 一种预防妊娠纹的香皂及其制备方法
EP3371238A1 (en) 2015-11-05 2018-09-12 Lubrizol Advanced Materials, Inc. Thermoformable dual network hydrogel compositions
KR101686399B1 (ko) * 2015-11-26 2016-12-15 코스맥스 유에스에이, 코퍼레이션 항노화용 화장료 조성물
CN108495646B (zh) * 2015-12-10 2022-07-08 路博润先进材料公司 用于治疗和/或护理皮肤、毛发、指甲和/或粘膜的化合物
BR112018015897B1 (pt) 2016-02-04 2022-03-03 Alastin Skincare, Inc Composição tópica anidra para promover a reparação da pele, composições tópicas para promover a restauração da pele, composição tópica para aliviar contusões causadas por um procedimento cosmético e uso das mesmas
US10493020B2 (en) 2016-04-14 2019-12-03 The Procter & Gamble Company Method of improving the appearance of periorbital dyschromia
US9872523B2 (en) * 2016-05-13 2018-01-23 Elvis Salkovic Piece of clothing for supporting sleep
WO2018014936A1 (en) * 2016-07-18 2018-01-25 Nuritas Limited Topical compositions
US11654293B2 (en) 2016-11-10 2023-05-23 The Bioregentech Institute, Inc. Laser assisted wound healing protocol and system
WO2018089954A1 (en) 2016-11-10 2018-05-17 BioRegentech Laser assisted wound healing protocol and system
EP3329930A1 (en) 2016-12-05 2018-06-06 Nuritas Limited Pharmaceuctical compositions
KR20240128130A (ko) 2016-12-05 2024-08-23 뉴리타스 리미티드 펩티드 wkdeagkplvk를 포함하는 조성물
EP3329905A1 (en) 2016-12-05 2018-06-06 Nuritas Limited Topical cosmetic compositions comprising an oligopeptide against anti-aging of the skin
WO2018134265A1 (en) 2017-01-17 2018-07-26 Forrest Michael David Therapeutic inhibitors of the reverse mode of atp synthase
CN106667788A (zh) * 2017-02-08 2017-05-17 广东科玮生物技术股份有限公司 一种含生长因子的面膜液及干式面膜
KR102087123B1 (ko) 2017-04-21 2020-03-10 유씨엘 주식회사 펩타이드와 해조류 추출물을 함유하는 나노에멀젼 및 그를 이용한 화장료 조성물
BR112020000123A2 (pt) * 2017-07-04 2020-07-07 Lubrizol Advanced Materials, Inc. composto, uso de um composto, composição cosmética, e, método para cuidado e/ou tratamento cosmético não terapêutico da pele, cabelos, unhas e/ou membranas mucosas
IL271845B2 (en) 2017-07-13 2024-06-01 Michael David Forrest Therapeutic modulators of the reverse mode of atp synthase
EP3661538A4 (en) 2017-08-03 2021-07-14 Alastin Skincare, Inc. COMPOSITIONS AND PROCEDURES FOR IMPROVING SLEEPING SKIN AND BODY CONTOUR
CN107365355B (zh) * 2017-08-07 2020-06-26 温州千瑞生物科技有限公司 抗皱纹的肽以及包含其的化妆品
CN107778349B (zh) * 2017-11-29 2021-05-04 陕西慧康生物科技有限责任公司 一种合成ghk醋酸盐的方法
KR102038366B1 (ko) * 2018-05-29 2019-10-30 주식회사 조인앤믹스 여드름 피부 개선용 화장료 조성물
US10980851B2 (en) * 2018-06-08 2021-04-20 The Procter & Gamble Company Topical skincare compositions comprising Centella asiatica selected triterpenes
US20210238229A1 (en) 2018-06-14 2021-08-05 University College Cork - National University Of Ireland, Cork Peptide for disease treatment
CN110652578A (zh) * 2018-06-29 2020-01-07 重庆合钰成贸易有限公司 女性舒柔养护凝胶及其制备方法
CN112367968B (zh) * 2018-07-06 2023-06-16 安医健有限公司 包含肽复合物作为有效成分的用于去除或吸附微尘的化妆品组合物
US11103455B2 (en) 2018-08-02 2021-08-31 ALASTIN Skincare, Inc. Liposomal compositions and methods of use
CN109010113B (zh) * 2018-08-28 2021-08-17 高宝化妆品（中国）有限公司 一种修复敏感肌肤的组合物及其应用
CN109431914B (zh) * 2018-12-27 2020-07-07 湖南御家化妆品制造有限公司 头皮养护组合物及其应用
BR112021022242A2 (pt) 2019-05-08 2022-01-18 Alastin Skincare Inc Composições e métodos para melhorar hematoma e para rejuvenescimento da pele
EP3990124A1 (en) * 2019-06-28 2022-05-04 L'Oréal Anti-aging compositions and skin masks containing anti-aging compositions
EP3783012A1 (en) 2019-08-20 2021-02-24 Nuritas Limited An antimicrobial peptide
JP2022545265A (ja) 2019-08-20 2022-10-26 ニューリタス リミテッド 筋萎縮を治療するためのペプチド
CN114980913B (zh) 2019-10-22 2025-09-30 努里塔斯有限公司 非酒精性脂肪性肝病的治疗
BR112022013127A2 (pt) * 2019-12-30 2022-09-06 Rodan & Fields Llc Composição, formulação tópica, método para induzir o reparo da barreira da pele e uso
EP3862014A1 (en) 2020-02-07 2021-08-11 Nuritas Limited Treatment of panx1 associated diseases
GB202004804D0 (en) * 2020-04-01 2020-05-13 Neuro Bio Ltd Skin
CN111909243B (zh) * 2020-08-04 2022-01-18 立康荣健(北京)生物医药科技有限公司 一种抗菌肽和抗菌止痒药物组合物及应用
WO2022051831A1 (pt) * 2020-09-11 2022-03-17 Chemyunion Ltda. Composição, uso de composição, método cosmético e método para modular a produção de sebo
CN114805489A (zh) * 2021-01-11 2022-07-29 四川好医生攀西药业有限责任公司 一类用于修复皮肤损伤或黏膜损伤的多肽及其应用
WO2022157548A1 (en) 2021-01-24 2022-07-28 Forrest Michael David Inhibitors of atp synthase - cosmetic and therapeutic uses
WO2022219008A1 (en) 2021-04-14 2022-10-20 University College Cork - National University Of Ireland, Cork Treatment of cerebrovascular events and neurological disorders
EP4322984A1 (en) 2021-04-14 2024-02-21 University College Cork-National University of Ireland Cork Psg1 for use in the treatment of osteoarthritis
CN113750216B (zh) * 2021-10-22 2022-10-25 北美生命科学(上海)有限公司 一种抗衰老的化妆品或药物
KR20250125272A (ko) * 2021-11-04 2025-08-21 쉔젠 윈키 테크놀로지 컴퍼니 리미티드 테트라펩타이드 유도체 및 이의 미용 조성물 또는 약학 조성물과 용도
CN114315968B (zh) * 2021-12-31 2022-10-18 深圳市维琪医药研发有限公司 一种九肽及其美容组合物或药用组合物和用途
WO2023184114A1 (zh) * 2022-03-28 2023-10-05 深圳市维琪科技股份有限公司 一种多肽及其美容组合物或药用组合物和用途
CN115192471B (zh) * 2022-07-13 2023-07-18 海南省麦吉丽生物科技有限公司 一种可以改善皮肤弹性的纳米乳凝胶、化妆品组合物及其制备和应用
EP4601669A1 (en) 2022-10-14 2025-08-20 University College Cork-National University of Ireland Cork Placenta expressed proteins for use in the treatment of tendon injury
CN116019735B (zh) * 2022-12-26 2025-03-25 深圳市维琪科技股份有限公司 多肽在制备用于舒缓皮肤的组合物中的新用途
CN116535463B (zh) * 2023-04-20 2023-10-31 深圳市维琪科技股份有限公司 活性肽及其组合物和用途
KR20250056445A (ko) * 2023-10-19 2025-04-28 (주) 수파드엘릭사 수족증후군 또는 수족피부반응의 예방 또는 치료용 약학 조성물
WO2025133254A2 (en) 2023-12-20 2025-06-26 Nuritas Limited Angiotensin-converting enzyme (ace) inhibiting peptides.
WO2025133189A1 (en) 2023-12-20 2025-06-26 Nuritas Limited Sleep promoting peptides and the use thereof
CN119143848B (zh) * 2023-12-26 2025-11-25 杭州湃肽生化科技有限公司 环七肽-4及其制备方法及应用
WO2026038945A1 (en) * 2024-08-16 2026-02-19 Winnox Cosmeceutics Sdn. Bhd. Peptides, compositions and methods of use
CN119101116A (zh) * 2024-10-23 2024-12-10 广州凡岛网络科技有限公司 一种抗衰多肽及其合成方法与应用
CN120058859B (zh) * 2025-04-29 2025-07-08 深圳市维琪科技股份有限公司 一种六肽化合物及其组合物和用途
CN120173070B (zh) * 2025-05-21 2025-08-08 湖南中晟全肽生物科技股份有限公司 抑制sost与lrp6结合的多肽及其应用

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2695035A1 (fr) 1992-08-25 1994-03-04 Lvmh Rech Gie Utilisation d'un ecdystéroïde pour la préparation de compositions cosmétiques ou dermatologiques destinées notamment à renforcer la fonction protectrice de la peau, et compositions ainsi obtenues.
FR2801504B1 (fr) 1999-11-26 2002-02-15 Lvmh Rech Extrait d'ajuga turkestanica et ses applications cosmetiques
FR2831058B1 (fr) 2001-10-18 2004-01-16 Jean Noel Thorel Composition cosmetique hydratante comprenant des aquaporines
WO2003037933A2 (de) * 2001-10-30 2003-05-08 Pentapharm Ag Dermopharmazeutisch und kosmetisch wirksame oligopeptide
JP2004168732A (ja) 2002-11-22 2004-06-17 Kanebo Ltd 活性酸素消去剤、ヒアルロン酸合成促進・分解抑制剤およびアクアポリン合成促進剤
FR2854897B1 (fr) * 2003-05-12 2007-05-04 Sederma Sa Compositions cosmetiques ou dermopharmaceutiques pour reduire les signes du vieillissement cutane.
ES2293753B1 (es) * 2004-04-28 2009-03-16 Lipotec, S.A. Uso de peptidos xikvav en preparacion de composiciones cosmeticas para mejorar la firmeza de la piel mediante el aumento de la adhesion celular.
JP2005343882A (ja) 2004-06-07 2005-12-15 Kanebo Cosmetics Inc ヒアルロン酸産生促進剤、アクアポリン合成促進剤、及び皮膚外用剤組成物
JP2006290873A (ja) 2005-03-14 2006-10-26 Rohto Pharmaceut Co Ltd アクアポリン発現促進剤
JP5118018B2 (ja) * 2005-04-15 2013-01-16 ヒューマン マトリックス サイエンシーズ、エルエルシー 植物由来のエラスチン結合タンパク質リガンドおよびその使用方法
EP1901817A2 (en) 2005-07-08 2008-03-26 The Procter and Gamble Company Personal care compositions and methods for the beautification of mammalian skin and hair
FR2889949B1 (fr) 2005-08-26 2014-01-10 Jean Noel Thorel Utilisation d'un actif cosmetique et/ou dermocosmetique a base d'extrait vegetal de pyrus malus
US20090130223A1 (en) 2006-04-27 2009-05-21 Ute Breitenbach Cosmetic preparation with aquaporin stimulators and the use thereof
FR2903015B1 (fr) 2006-06-30 2012-07-20 Courtage Et De Diffusion Codif Internat Soc D Utilisation d'au moins un extrait d'une algue brune et/ou d'une plante halophyte pour la realisation de compositions cosmetiques.
KR20080024868A (ko) 2006-09-15 2008-03-19 전남대학교산학협력단 수분채널단백질인 아쿠아포린 및 이를 조절하는 여성의 질윤활제
DE102007024384A1 (de) 2007-05-23 2008-11-27 Henkel Ag & Co. Kgaa Kosmetische und dermatologische Zusammensetzungen gegen trockene Haut
FR2925501B1 (fr) 2007-12-21 2012-12-14 Vincience Peptide activateur de la synthese des aquaporines et composition cosmetique et/ou pharmaceutique le contenant
FR2925500B1 (fr) 2007-12-21 2011-05-06 Vincience Peptide derive d'une proteine de la famille des aquaporines et composition cosmetique et/ou pharmaceutique le contenant
ES2330291B1 (es) * 2008-02-29 2010-10-18 Lipotec Sa Peptidos utiles en el tratamiento de la piel, mucosas y/o cuero cabelludo y su uso en composiciones cosmeticas o farmaceuticas.
WO2009106934A1 (en) 2008-02-29 2009-09-03 Chemyunion Química Ltda Angico-branco (piptadenia colubrina) extracts for use in cosmetic and dermatological formulations
FR2928090B1 (fr) 2008-03-03 2014-10-10 Lvmh Rech Utilisation d'un extrait de l'orchidee vanda coerulea comme agent hydratant de la peau
FR2941232B1 (fr) * 2009-01-16 2014-08-08 Sederma Sa Nouveaux peptides, compositions les comprenant et utilisations cosmetiques et dermo-pharmaceutiques.
ES2349972B1 (es) * 2009-02-16 2011-11-24 Lipotec, S.A. Péptidos útiles en el tratamiento y/o cuidado de la piel, mucosas y/o cuero cabelludo y su uso en composiciones cosméticas o farmacéuticas.
US20120021029A1 (en) * 2009-04-17 2012-01-26 Lipotec, S.A. Peptides used in the treatment and/or care of the skin and/or hair and their use in cosmetic or pharmaceutical compositions
FR2954697B1 (fr) * 2009-12-24 2016-11-04 Isp Investments Inc Composition cosmetique et/ou pharmaceutique comprenant un extrait de caroube en tant qu'agent actif activateur de l'expression des aquaporines

Also Published As

Publication number Publication date
CN103314005B (zh) 2016-08-10
JP6075650B2 (ja) 2017-02-08
KR101988675B1 (ko) 2019-06-12
AU2012234366A1 (en) 2013-07-18
BR112013020005A2 (pt) 2017-10-31
KR20140043727A (ko) 2014-04-10
EP2651963A1 (en) 2013-10-23
BR112013020005A8 (pt) 2018-01-09
JP2014510090A (ja) 2014-04-24
US9067967B2 (en) 2015-06-30
ES2397890A1 (es) 2013-03-12
WO2012130771A1 (en) 2012-10-04
ES2397890B1 (es) 2014-02-07
CN103314005A (zh) 2013-09-18
US20140120141A1 (en) 2014-05-01
AU2012234366B2 (en) 2017-04-13
EP2651963B1 (en) 2016-03-23

Similar Documents

Publication Publication Date Title
PE20210050A1 (es) Nuevos compuestos de sulfonamida carboxamida
EA202091774A1 (ru) Гербицидно-активные 3-фенилизоксазолин-5-карбоксамиды производных циклопентенилкарбоновой кислоты
MX378319B (es) Composiciones para el cuidado bucal y metodos de uso.
AR063528A1 (es) Peptidos inhibidores de la exocitosis neuronal
CO6430467A2 (es) Péptidos útiles en el tratamiento y/o cuidado de la piel y/o cabello y su uso en composiciones cosméticas o farmacéuticas
ECSP12011857A (es) Compuestos de dióxido de iminotiadiazina como inhibidores de bace, composiciones, y su uso
MX353067B (es) Composiciones de peptidos de glp-1 y preparaciones de las mismas.
AR073829A1 (es) Variantes de inmunoglobulinas y sus usos.
PE20241305A1 (es) Analogos de amilina
RU2017123388A (ru) Пептиды и их применение в уходе за кожей
MX392572B (es) Compuestos del péptido yy (pyy) selectivos y sus usos.
MX388822B (es) Composiciones que comprenden peptido wkdeagkplvk.
CY1123780T1 (el) Ενωσεις για την προωθηση της αναπτυξης των μαλλιων ή/και την αναστολη ή καθυστερηση της τριχοπτωσης στον ανθρωπο και συνθεσεις για τετοιου ειδους χρησεις
BR112017015833A2 (pt) compostos anti-senescência e usos dos mesmos
AR072610A1 (es) Composiciones para el tratamiento del dolor y/o la inflamacion
ES2397889A1 (es) PÉPTIDOS MODULADORES DE PGC-1Alfa.
AR090439A1 (es) Lipopeptidos antimicrobianos cortos
CL2018003319A1 (es) Compuestos de mic-1 y usos de estos.
MX2020001083A (es) Composiciones que comprenden aminoacidos para su uso en el tratamiento de enfermedades relacionadas con la disfuncion mitocondrial.
AR060251A1 (es) Peptidos sinteticos utiles en el tratamiento de la piel y su uso en composiciones cosmeticas o dermofarmaceuticas
EA201590329A1 (ru) Использование полученных из pedf полипептидов для стимуляции регенерации или артериогенеза в мышцах или сухожилиях
ES2570458T3 (es) Peptidomiméticos fijados sobre una matriz con actividad moduladora de CXCR7
MY189759A (en) Conjugate of finasteride with peptide
MX2023014015A (es) Formulación aminoácidica hidratante y método de uso.
EA202190888A1 (ru) Пептид для применения в косметике